PCSK9 and diabetes mellitus: Evidence from clinical research also demonstrates that elevated PCSK9 is associated with systematic inflammation and platelet activation, while high levels of PCSK9 predict a greater risk of recurrent ischemia, especially for those with diabetes and ongoing inflammation [33,34,35].